LAUSR

ABSTRACT Background Depression in infertile female patients not only influences mental well-being but also affects the effectiveness of infertility treatment. Our study aims to describe the current situation of depressive symptoms among women undergoing IVF treatment and some associated factors, thereby providing evidence for patient healthcare management and hospital quality improvement. Methods A descriptive cross-sectional study was conducted with 180 infertile women visiting the National Hospital of Obstetrics and Gynecology during IVF treatment from February to April 2023. The BDI-II scale was used to measure depressive symptoms. Participants were also inquired about demographics and some information on reproductive history and IVF treatment. Results The depressive symptoms prevalence was 15%, with a cut-off score >13 on the BDI-II scale. Some factors related to depression in infertile women undergoing IVF treatment are education level (OR = 3.9), infertility duration longer than 2 years, and more than 5 years (OR = 2.7; OR = 3.8); causes of infertility from both husband and wife (OR = 3.7); duration of IVF treatment more than 3 years (OR = 3.1); with once or twice or more failed IVF treatment (OR = 1.9; OR = 5.8), and family pressure (OR = 9.6). Conclusion Assessment of depressive symptoms should be assessed at an early stage among infertile female patients for timely mental health support.